Luis Féliz

2.7k citations
27 papers · 1.7k indexed · 2 hit papers · h-index 14
Topics
Fibroblast Growth Factor Research (21 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers)Pancreatic and Hepatic Oncology Research (7 papers)

In The Last Decade

Luis Féliz

27 papers receiving 1.7k citations

Hit Papers

Pemigatinib for previously treated, locally advanced or m...202020262022202420202020250500750

Peers

Luis Féliz
Comparison fields: 5 of 57
  • Surgery 1.2k
  • Oncology 896
  • Molecular Biology 617
  • Pulmonary and Respiratory Medicine 517
  • Cancer Research 285
Replace Christine Lihou with:
Christine Lihou United States
Raed Moh’d Taiseer Al-Rajabi United States
David Gallinson United States
Tomoki Shirota Japan
Stefano Cereda Italy
Cinta Hierro Spain
Aris Polyzos Greece
Marco Dal Molin United States
I Miyazaki Japan
Robin Katie Kelley United States
Luis Féliz relative to Christine Lihou United States Christine Lihou's profile →
Citations per field
00.5×1.5×
Christine Lihou · 1×
Citations per year

Countries citing papers authored by Luis Féliz

Since Specialization
Citations

This map shows the geographic impact of Luis Féliz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Féliz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Féliz more than expected).

Fields of papers citing papers by Luis Féliz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Féliz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Féliz. The network helps show where Luis Féliz may publish in the future.

Co-authorship network of co-authors of Luis Féliz

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Féliz. A scholar is included among the top collaborators of Luis Féliz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Féliz. Luis Féliz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 20
3 22
4 125
5 1
6 19
7
Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinibbreakdown →
191
8
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 studybreakdown →
975
9 125
10 2
11 10
12 4
13 30
14 2
15 13
16 10
17 1
18 21
19 14
20 26

About Luis Féliz

Luis Féliz is a scholar working on Oncology, Surgery and Molecular Biology, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Oncology (896 citations), Surgery (1.2k citations) and Cancer Research (285 citations). Luis Féliz has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Christine Lihou, Hui‐Ling Zhen, Davide Melisi, Antoine Hollebecque, Ghassan K. Abou‐Alfa, Tao Ji, Mitesh J. Borad, Arndt Vogel, Eric Van Cutsem and Do‐Youn Oh. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026